Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
ALLO

Updated 10/6/2026, 9:41 AM ET.

ALLO

Allogene Therapeutics, Inc.

Sale$62,958

Douglas Earl Martin

SVP, General Counsel

29,697 shat $2.12Filed Aug 25, 4:43 PM ETFiling

Read from public SEC filings. Not financial advice.